
Quest Health, Rimidi Partner to Improve Diabetes RPM Outcomes
Early data reveals 11% average blood glucose reduction and up to 1% A1C improvement for participating patients after just two months Quest Health Solutions, a
Early data reveals 11% average blood glucose reduction and up to 1% A1C improvement for participating patients after just two months Quest Health Solutions, a
Impilo, a leader in enabling at-home healthcare through connected device and diagnostics operations, is proud to be a founding member of the newly established Remote Patient
Fuel up with free Health Tech Insights